This document discusses the epigenetics of kidney diseases. It begins by defining epigenetics as heritable changes in gene expression and phenotype that are not caused by changes in DNA sequence, such as DNA methylation and histone protein modifications. It then focuses on the role of DNA methylation in chronic kidney disease (CKD) and diabetic nephropathy (DN), explaining how hyperglycemia and transforming growth factor beta can induce genes related to apoptosis, fibrosis, and glomerular dysfunction through changes in DNA methylation. Studying the epigenetics of the kidney is important to discover new targeted treatments for kidney diseases, such as inhibitors of DNA methyltransferases and histone deacetylases, which could provide more selective